RETRACTED: Efficacy and Safety of Different Thermal Ablation Modalities for Papillary Thyroid Microcarcinoma: A Network Meta-Analysis

Table 1

The basic characteristics and quality evaluation of literature.

Author	Country	Year	Type of study	Sex(M/F)	Age(s)	Sample sizes	Interventions	PTMC diameters (mm)	Outcomes	NOS scores
Shen et al. [14]	China	2019	Cohort study	16/29	43.7 ± 6.6	45	RFA	6.12 ± 1.23	①②③	5
				24/28	40.5 ± 7.8	52	MWA	6.21 ± 1.16
Sun and Dong [15]	China	2018	Cohort study	20/27	42.66 ± 4.19	47	RFA	6.17 ± 1.11	①②③	6
				18/21	43.09土5.14	39	MWA	6.04 ± 1.2
Gong et al. [16]	China	2019	Cohort study	26/53	49.32 ± 7.48	75	MWA	6.31 ± 1.71	③	5
				23/52	49.67 ± 7.39	79	RFA	6.77 ± 1.68
				20/53	48.86 ± 7.42	73	Surgery	6.28 ± 1.69
Feng et al. [17]	China	2019	Cohort study	26/76	47.4 ± 11.2	102	RFA	5.9 ± 1.7	①②③④⑤	5
				23/92	43.9 ± 10.7	115	Surgery	6.3 ± 2.2
Zhou et al. [18]	China	2020	Cohort study	14/36	42.16 ± 10.28	50	Surgery	4.30 ± 1.25	①②③④⑤	5
				11/40	44.72 ± 9.94	51	MWA	4.46 ± 1.39
Yao et al. [19]	China	2020	Cohort study	19/101	45.86 ± 8.30	120	MWA	5.89 ± 1.12	①②③④⑤	5
				22/98	46.02 ± 8.11	120	Surgery	5.96 ± 1.05
Li et al. [20]	China	2018	Cohort study	14/32	43.63 ± 9.27	46	MWA	4.49 ± 1.55	①②③④⑤	7
				13/33	49.59 ± 9.0	46	Surgery	4.29 ± 1.37
Xiao et al. [21]	China	2021	Cohort study	19/72	40.7 ± 9.3	91	RFA	1.4 ± 0.2 cm	①②③⑤	5
				23/68	40.2 ± 10.4	91	Surgery	1.4 ± 0.2 cm
Zhou et al. [22]	China	2020	Cohort study	7/26	37.9 ± 10.1	33	MWA	5.0 ± 1.4	①②③④⑤	6
				11/23	41.8 ± 13.4	34	LA	4.5 ± 1.6
Li et al. [23]	China	2019	Cohort study	36/132	47.36 ± 10.75	168	MWA	4.67 ± 1.65	①②③	6
				29/114	49.18 ± 11.41	143	Surgery	4.59 ± 1.77
Zhu et al. [24]	China	2020	Cohort study	16/28	45 ± 17	44	EA + RFA	5.78 ± 1.55	③	6
				15/29	46 ± 17	44	RFA	5.89 ± 1.37
Song et al. [25]	China	2021	Cohort study	18/97	44.9 ± 10.4	115	RFA	6.5 ± 1.9	①②③④⑤	7
				19/84	45.4 ± 9.9	103	Surgery	6.9 ± 1.6

① Recurrence Rate; ② Lymph Node Metastasis Rates; ③ Complication Rates; ④ Length of Stay; ⑤ Surgical Time.